Johnson & Johnson Single-Shot COVID-19 Vaccine Demonstrated a Durable Immune Response and Elicited Neutralising Antibody Responses Against Delta and Other SARS-CoV-2 Variants of Concern in Data Published in New England Journal of Medicine
- EMEA Innovative Medicine
- Johnson & Johnson Single-Shot COVID-19 Vaccine Demonstrated a Durable Immune Response and Elicited Neutralising Antibody Responses Against Delta and Other SARS-CoV-2 Variants of Concern in Data Published in New England Journal of Medicine
Johnson & Johnson Single-Shot COVID-19 Vaccine Demonstrated a Durable Immune Response and Elicited Neutralising Antibody Responses Against Delta and Other SARS-CoV-2 Variants of Concern in Data Published in New England Journal of Medicine
- X (Twitter)
Copy link